Basilea Pharmaceutica AG (BSLN) — Defensive Interval Ratio
Basilea Pharmaceutica AG (BSLN) has a Defensive Interval Ratio of 2639 days as of December 2025. Defensive assets of CHF355.77 Million (cash CHF159.80 Million, short-term investments CHF132.70 Million, receivables CHF63.28 Million) cover 2639 days of daily cash needs of CHF134.84K/day. Check Basilea Pharmaceutica AG (BSLN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Basilea Pharmaceutica AG Defensive Interval Ratio (2002–2025)
This chart shows how Basilea Pharmaceutica AG's Defensive Interval Ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 2639 days, meaning defensive assets of CHF355.77 Million can fund 2639 days of operations without new revenue. Also explore net asset growth rate of Basilea Pharmaceutica AG to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Basilea Pharmaceutica AG (2002–2025)
The table below presents the year-by-year Defensive Interval Ratio for Basilea Pharmaceutica AG from 2002 to 2025, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Basilea Pharmaceutica AG.
| Year | DIR (days) | Defensive Assets (CHF) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2438 days | CHF328.67 Million | CHF134.84K/day | CHF132.70 Million | CHF132.70 Million | ▲ +1129 days |
| 2024 | 1308 days | CHF163.30 Million | CHF124.82K/day | CHF106.71 Million | CHF11.00K | ▲ +299 days |
| 2023 | 1009 days | CHF131.56 Million | CHF130.39K/day | CHF51.83 Million | CHF51.83 Million | ▲ +221 days |
| 2022 | 788 days | CHF161.66 Million | CHF205.07K/day | CHF49.96 Million | CHF50.00 Million | ▲ +455 days |
| 2021 | 334 days | CHF159.45 Million | CHF477.83K/day | CHF0.00 | CHF95.00 Million | ▼ -715 days |
| 2020 | 1048 days | CHF144.07 Million | CHF137.43K/day | CHF10.65 Million | CHF101.02 Million | ▲ +268 days |
| 2019 | 780 days | CHF161.34 Million | CHF206.83K/day | CHF56.52 Million | CHF76.52 Million | ▼ -426 days |
| 2018 | 1206 days | CHF220.35 Million | CHF182.70K/day | CHF135.63 Million | CHF50.00 Million | ▲ +170 days |
| 2017 | 1036 days | CHF225.65 Million | CHF217.78K/day | CHF150.62 Million | CHF60.00 Million | ▼ -6 days |
| 2016 | 1042 days | CHF208.12 Million | CHF199.76K/day | CHF205.63 Million | CHF0.00 | ▲ +760 days |
| 2015 | 282 days | CHF53.17 Million | CHF188.59K/day | CHF- | CHF51.62 Million | ▼ -181 days |
| 2014 | 463 days | CHF78.20 Million | CHF169.02K/day | CHF- | CHF70.00 Million | ▼ -520 days |
| 2013 | 982 days | CHF162.30 Million | CHF165.22K/day | CHF- | CHF155.00 Million | ▲ +163 days |
| 2012 | 819 days | CHF131.50 Million | CHF160.58K/day | CHF- | CHF120.00 Million | ▲ +415 days |
| 2011 | 404 days | CHF37.67 Million | CHF93.30K/day | CHF- | CHF25.00 Million | ▼ -617 days |
| 2010 | 1021 days | CHF160.97 Million | CHF157.67K/day | CHF- | CHF150.00 Million | ▲ +287 days |
| 2009 | 734 days | CHF70.00 Million | CHF95.37K/day | CHF- | CHF65.00 Million | ▼ -1146 days |
| 2008 | 1880 days | CHF223.10 Million | CHF118.67K/day | CHF- | CHF215.00 Million | ▼ -742 days |
| 2007 | 2622 days | CHF258.30 Million | CHF98.50K/day | CHF- | CHF255.00 Million | ▲ +679 days |
| 2006 | 1944 days | CHF145.66 Million | CHF74.95K/day | CHF- | CHF140.00 Million | ▼ -1946 days |
| 2005 | 3889 days | CHF202.69 Million | CHF52.11K/day | CHF- | CHF200.00 Million | ▲ +1528 days |
| 2004 | 2361 days | CHF136.91 Million | CHF57.98K/day | CHF- | CHF136.25 Million | ▲ +2227 days |
| 2003 | 134 days | CHF2.33 Million | CHF17.38K/day | CHF- | CHF1.25 Million | ▼ -1816 days |
| 2002 | 1950 days | CHF77.54 Million | CHF39.76K/day | CHF- | CHF71.00 Million | — |